Bioaccelerate Portfolio Company Inncardio Inc. Enters into Licence and Co-development Agreement for INC 105 with the University of Strathclyde
28 sept. 2004 12h59 HE
|
Gardant Pharmaceuticals, Inc.
NEW YORK, Sept. 28, 2004 (PRIMEZONE) -- Bioaccelerate Holdings, Inc. (OTCBB:BACL) a pharmaceutical development organization today announced that one of its portfolio companies, Inncardio Inc., a...
Bioaccelerate Portfolio Company Inncardio Inc. Enters into Licence and Co-development Agreement for INC 105 with the University of Strathclyde
28 sept. 2004 12h01 HE
|
Gardant Pharmaceuticals, Inc.
NEW YORK, Sept. 28, 2004 (PRIMEZONE) -- Bioaccelerate Holdings, Inc. (OTCBB:BACL) a pharmaceutical development organization today announced that one of its portfolio companies, Inncardio Inc., a...
UPDATE: Bioaccelerate Portfolio Company Enhance Biotech to Merge with Privately-Held Ardent Pharmaceuticals -- the World Leader in the Discovery and Development of Delta Receptor Compounds
12 août 2004 12h16 HE
|
Gardant Pharmaceuticals, Inc.
NEW YORK, Aug. 12, 2004 (PRIMEZONE) -- Bioaccelerate, Inc. , a pharmaceutical development organisation has today announced that one of its portfolio companies, Enhance Biotech Inc (Pink Sheets:EBOI),...
Bioaccelerate Portfolio Company Enhance Biotech to Merge with Privately-Held Ardent Pharmaceuticals -- the World Leader in the Discovery and Development of Delta Receptor Compounds
12 août 2004 10h53 HE
|
Gardant Pharmaceuticals, Inc.
NEW YORK, Aug. 12, 2004 (PRIMEZONE) -- Bioaccelerate, Inc. , a pharmaceutical development organisation has today announced that one of its portfolio companies, Enhance Biotech Inc (Pink Sheets:EBOI),...